Hypertension is associated with alterations in the vascular structure, which in turn enhance the risk of cardiovascular events. Notably, anti-hypertensive treatment may prevent or regress the changes of arterial wall structures. Lercanidipine is a third-generation CCB with peculiar pharmaceutical properties. Enalapril is an effective drug acting on the renin–angiotensin–aldosterone axis. This commentary discusses the vascular effects of the lercanidipine/enalapril combination, and comments on their potential clinical relevance.
Parati, G. (2016). Vascular effects of the lercanidipine/enalapril combination: clinical relevance. CURRENT MEDICAL RESEARCH AND OPINION, 32(sup2), 25-28.
Citazione: | Parati, G. (2016). Vascular effects of the lercanidipine/enalapril combination: clinical relevance. CURRENT MEDICAL RESEARCH AND OPINION, 32(sup2), 25-28. |
Tipo: | Articolo in rivista - Articolo scientifico |
Carattere della pubblicazione: | Scientifica |
Presenza di un coautore afferente ad Istituzioni straniere: | No |
Titolo: | Vascular effects of the lercanidipine/enalapril combination: clinical relevance |
Autori: | Parati, G |
Autori: | PARATI, GIANFRANCO (Primo) (Corresponding) |
Data di pubblicazione: | 2016 |
Lingua: | English |
Rivista: | CURRENT MEDICAL RESEARCH AND OPINION |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1080/03007995.2016.1218837 |
Appare nelle tipologie: | 01 - Articolo su rivista |